SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Fowkes F. Gerry R.)
 

Sökning: WFRF:(Fowkes F. Gerry R.) > A Structured Review...

  • Hess, Connie N.University of Colorado School of Medicine (författare)

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease with a Focus on Revascularization : A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

  • Artikel/kapitelEngelska2017

Förlag, utgivningsår, omfång ...

  • 2017
  • 22 s.

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:28a6923d-981f-42f0-ae16-4bbe5d9fdba3
  • https://lup.lub.lu.se/record/28a6923d-981f-42f0-ae16-4bbe5d9fdba3URI
  • https://doi.org/10.1161/CIRCULATIONAHA.117.024469DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:for swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Peripheral artery disease affects >200 million people worldwide and is associated with significant limb and cardiovascular morbidity and mortality. Limb revascularization is recommended to improve function and quality of life for symptomatic patients with peripheral artery disease with intermittent claudication who have not responded to medical treatment. For patients with critical limb ischemia, the goals of revascularization are to relieve pain, help wound healing, and prevent limb loss. The baseline risk of cardiovascular and limb-related events demonstrated among patients with stable peripheral artery disease is elevated after revascularization and related to atherothrombosis and restenosis. Both of these processes involve platelet activation and the coagulation cascade, forming the basis for the use of antiplatelet and anticoagulant therapies to optimize procedural success and reduce postprocedural cardiovascular risk. Unfortunately, few high-quality, randomized data to support use of these therapies after peripheral artery disease revascularization exist, and much of the rationale for the use of antiplatelet agents after endovascular peripheral revascularization is extrapolated from percutaneous coronary intervention literature. Consequently, guideline recommendations for antithrombotic therapy after lower limb revascularization are inconsistent and not always evidence-based. In this context, the purpose of this structured review is to assess the available randomized data for antithrombotic therapy after peripheral arterial revascularization, with a focus on clinical trial design issues that may affect interpretation of study results, and highlight areas that require further investigation.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Norgren, LarsLund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine(Swepub:lu)kir-lno (författare)
  • Ansel, Gary M.Örebro University (författare)
  • Capell, Warren H.University of Colorado School of Medicine (författare)
  • Fletcher, John P.University of Colorado School of Medicine (författare)
  • Fowkes, F. Gerry R.University of Sydney (författare)
  • Gottsäter, AndersLund University,Lunds universitet,Vaskulära sjukdomar - kliniska studier,Forskargrupper vid Lunds universitet,Vascular Diseases - Clinical Research,Lund University Research Groups,University of Edinburgh(Swepub:lu)medf-ago (författare)
  • Hitos, KerrySkåne University Hospital,Lund University (författare)
  • Jaff, Michael R.University of Sydney (författare)
  • Nordanstig, JoakimHarvard Medical School (författare)
  • Hiatt, William R.University of Colorado School of Medicine,Sahlgrenska University Hospital (författare)
  • University of Colorado School of MedicineInstitutionen för kliniska vetenskaper, Malmö (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Circulation135:25, s. 2534-25550009-7322

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy